ADA Scientific Sessions 2026 Abstract
Mazdutide vs. Semaglutide in Chinese Adults with Type 2 Diabetes and Obesity (DREAMS-3): A Randomised, Open-Label, Phase 3b Trial
Trial in peopleInterventions
Papers by Huan Deng
6 results
- ADA Scientific Sessions 2026 Abstract
Efficacy and Safety of Mazdutide 9 mg in Chinese Adults with Obesity: Results from the Phase 3 GLORY-2 Trial
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI3032, a Novel Oral Nonpeptide GLP-1 Receptor Agonist: Single- and Multiple-Ascending Dose Studies in Chinese Adults
Trial in peopleInterventions - ADA Scientific Sessions 2026 Abstract
Safety, Tolerability, and Pharmacokinetics of Once-Weekly Mazdutide in Chinese Adolescents with Obesity: A Phase 1b Trial
Trial in peopleInterventions
- AHA Scientific Sessions 2025 Abstract
Safety, Pharmacokinetics, and Pharmacodynamics of SGB-3908, A siRNA Targeting AGT in Healthy and Mildly Hypertensive Subjects
Trial in peopleInterventions - ADA Scientific Sessions 2025 Abstract
Mazdutide vs. Placebo as Monotherapy in Patients with Type 2 Diabetes (DREAMS-1)
Trial in peopleInterventions